文献速递运动医学

口服避孕激素对前交叉韧带强度的影响

The Effect of Oral Contraceptive Hormones on Anterior Cruciate Ligament Strength.
PubMed 文献 · Am J Sports Med · 2019-11-25

本研究在大鼠模型中比较了五种临床常用口服避孕药(OCs)对前交叉韧带(ACL)强度的影响。结果显示,仅炔诺酮、屈螺酮+炔雌醇、双醋炔诺醇+炔雌醇和炔诺酮+炔雌醇治疗组的大鼠ACL强度显著高于未治疗对照组,且孕激素/雌激素比例较高的配方可增加I型胶原表达并降低基质金属蛋白酶-1表达。结论提示高孕激素/雌激素比例的OCs可能对ACL更具保护作用。

要点

  • 高孕激素/雌激素比例的口服避孕药可能提高大鼠ACL强度。
  • 仅炔诺酮及含屈螺酮、双醋炔诺醇、炔诺酮的复方OCs显著增加ACL强度。
  • 高比例配方增加I型胶原表达并降低MMP-1表达。

核心结论

  • 孕激素/雌激素比例较高的口服避孕药配方可能比低比例配方对ACL更具保护作用。

研究设计与样本

  • 对照实验室研究,共36只雌性大鼠,每组6只,分别接受5种临床用口服避孕药或不予治疗,每日灌胃20天(4个性周期)。

主要发现

  • ACL最大载荷(断裂前)未因口服避孕药治疗而显著改善。

临床怎么用

  • 高孕激素/雌激素比例的口服避孕药配方可能通过降低松弛素对ACL的作用,降低女性运动员的ACL损伤风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Women are 2 to 9 times more likely to experience an anterior cruciate ligament (ACL) injury than men. Various hormones including relaxin, progesterone, and estrogen influence ACL strength. Oral contraceptives (OCs) alter these hormone levels; however, studies have yet to comprehensively compare different OCs' effects on the ACL. HYPOTHESIS: OCs with increased progestin-to-estrogen ratios will (1) increase ACL collagen expression, (2) decrease ACL matrix metalloproteinase expression, and (3) increase ACL strength. STUDY DESIGN: Controlled laboratory study. METHODS: Untreated female rats were compared with rats treated with 1 of 5 clinically used OCs: norethindrone (NE) only, NE plus ethinylestradiol (EE), etynodiol diacetate (ED) plus EE, norgestimate (NG) plus EE, and drospirenone (DS) plus EE. Doses were scaled from human doses to account for differences in bioavailability and body weight, and OCs were administered daily via oral gavage for 4 rat estrous cycles (20 days). A total of 36 rats were then sacrificed (6 rats/group). ACLs underwent biomechanical testing to assess ACL strength, stiffness, and maximum load before failure. ACL specimens were also isolated for quantitative real-time polymerase chain reaction analysis to assess collagen, matrix metalloproteinase, and relaxin receptor-1 expression. RESULTS: While the primary structural property of interest (ACL maximum load before failure) was not significantly improved by OC treatment, the main material property of interest (ACL strength) in rats treated with NE only, DS + EE, ED + EE, and NE + EE was significantly increased compared with untreated controls (P = .001, P = .004, P = .004, and P = .04, respectively). The order from strongest to weakest ACLs, which was also the same order as the highest to lowest progestin-to-estrogen ratios, was groups treated with NE only, DS + EE, ED + EE, NE + EE, and lastly NG + EE. Higher ratio formulations also increased the expression of type I collagen (P = .02) and decreased the expression of matrix metalloproteinase-1 (P = .04). CONCLUSION: OC formulations with higher progestin-to-estrogen ratios may be more protective for the ACL than formulations with lower ratios. CLINICAL RELEVANCE: OC formulations with high progestin-to-estrogen ratios may benefit female athletes by reducing their ACL injury risk by decreasing the effects of relaxin on the ACL.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Konopka JA, Hsue L, Chang W, et al. The Effect of Oral Contraceptive Hormones on Anterior Cruciate Ligament Strength. Am J Sports Med. 2019. PMID: 31765227. doi:10.1177/0363546519887167

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。